Liver transplantation for non-resectable colorectal liver metastasis: where we are and where we are going
- 24 April 2020
- journal article
- review article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 405 (3) , 255-264
Abstract
Purpose Almost 50% of patients diagnosed with colorectal cancer (CRC) will develop liver metastasis (LM). Although their only long-term curative treatment is surgery, less than half of these patients can be eventually resected. Therefore, palliative chemotherapy is offered as a definitive option, though with poor results. Recently, the University of Oslo group has published encouraging results in the treatment of these patients with liver transplantation (LT), whereby worldwide interest in this option has been renewed. Methods A literature review of LT for patients with unresectable colorectal metastasis was performed. This included information regarding patient selection, complications, overall survival (OS) and disease-free survival (DFS), immunosuppression, chemotherapy, and description of the ongoing trials. Results Improvements in OS and DFS have been observed in consecutive published prospective trials, as patient selection has been refined. Papers reporting OS of patients who randomly presented similar selection criteria also exhibited good results. Conclusion LT within the available therapeutic options in patients with CRC-LM seems to be a compelling alternative in carefully selected patients. The ongoing trials will provide valuable information regarding selection criteria, immunosuppressive therapy and different modalities of adjuvant chemotherapy, which are, to our knowledge, the vital platform of LT in CRC-LM. Although some of the developing techniques involve living donors, graft availability for these patients remains a matter of major concern.Keywords
This publication has 56 references indexed in Scilit:
- Graft Rejection Occurring in Post–Liver Transplant Patients Receiving Cytotoxic Chemotherapy: A Case SeriesLiver Transplantation, 2009
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Liver transplantation for primary and metastatic liver cancersTransplant International, 2008
- Surgery for cholangiocarcinoma: the role of liver transplantationHPB, 2008
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Cancer despite immunosurveillance: immunoselection and immunosubversionNature Reviews Immunology, 2006
- Use of Extended Criteria Livers Decreases Wait Time for Liver Transplantation Without Adversely Impacting Posttransplant SurvivalAnnals of Surgery, 2006
- Genetic Detection of Lymph Node MicrometastasesTransplantation, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Auxiliary Partial Liver Transplantation for End-Stage Chronic Liver DiseaseNew England Journal of Medicine, 1988